|
|||||
|
|
Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors |
|
| Authors: | Ying Zheng Ruth Kim Ting Yu Julie A. Gayle Christina L. Wassel Jill Dreyfus Hemant Phatak Saby George |
| Affiliation: | 1. EMD Serono, Rockland, Massachusetts, USA;2. Pfizer Inc, New York, New York, USA;3. Premier Applied Sciences, Premier Inc, Charlotte, North Carolina, USA;4. Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA |
| Abstract: | |
| Keywords: | Immune checkpoint inhibitors Immune-related adverse events Real-world study Clinical outcomes Economic outcomes |